Skovronsky Daniel 4
4 · ELI LILLY & Co · Filed Feb 4, 2025
Insider Transaction Report
Form 4
Skovronsky Daniel
EVP, CS&PO & Pres. LRL
Transactions
- Exercise/Conversion
Restricted Stock Unit
2025-02-01−8,989→ 0 totalFrom: 2025-02-01Exp: 2025-02-01→ Common Stock (8,989 underlying) - Exercise/Conversion
Common Stock
2025-02-01+8,989→ 126,892 total - Tax Payment
Common Stock
2025-02-01$811.08/sh−4,003.64$3,247,272→ 122,888.36 total
Holdings
- 72,359(indirect: By Trust)
Common Stock
- 3,257(indirect: By Spouse)
Common Stock
Footnotes (2)
- [F1]The reporting person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.
- [F2]Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock.